JASPER THERAPEUTICS, INC. Stock Issued During Period, Shares, Purchase of Assets
JASPER THERAPEUTICS, INC. (JSPR) reported Stock Issued During Period, Shares, Purchase of Assets of 499.99 thousand shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets · last filed 2025-08-13
- 2025-06-30: Stock Issued During Period, Shares, Purchase of Assets 6 month 499.99K shares.
| Period end | Stock Issued During Period, Shares, Purchase of Assets 6 month |
|---|---|
| 2025-06-30 | 499.99K shares 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |